CN
About
Company overview
Leadership
Science
Pipeline
Partnership
News
Press release
Media coverage
Publication
Career
Contact
0
Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress
Release date: Jul 15, 2022
Previous : There is nothing.
Next : TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature